Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TrimSpa’s future?

This article was originally published in The Tan Sheet

Executive Summary

Goen Technologies, subsidiary company TrimSpa Inc. and its recently deceased spokesperson, Anna Nicole Smith, were named in a class-action lawsuit alleging false and misleading marketing for the TrimSpa X32 weight-loss supplement. The suit was filed Feb. 5 in the California Superior Court of Los Angeles County. Plaintiffs are asking for unspecified damages, restitution and an injunction preventing TrimSpa from making future weight-loss claims. The class action suit quickly follows Goen Technologies' and related marketers' $1.5 mil. settlement with FTC over allegations of unsubstantiated weight-loss claims (1"The Tan Sheet" Jan. 8, 2007, p. 4). TrimSpa's recent legal trouble in conjunction with Smith's death does not bode well for the future of the brand, according to brand consultant Robert K. Passikoff, Ph.D. Not only does the combination of circumstances deliver "too big a hit" for TrimSpa to recover, but there may also be reverberations across the entire weight-loss supplement category, Passikoff said....

You may also be interested in...



FTC Supplement Settlements Spotlight Bayer, Mark First Hoodia Action

Bayer "went too far" with weight-loss and -control claims for its One-A-Day WeightSmart product and violated a 1991 sanction the product's previous owner agreed to, the Federal Trade Commission said Jan. 4 when it announced a record $3.2 million fine against the consumer healthcare giant

QUOTED. 9 March 2021. Matthew Trerotola.

Splitting Colfax into separate fabrication technology and specialty medical technology businesses will help both sides of the business grow, CEO Matthew Trerotola said recently.

Catchup Capsule: Key APAC Insights You Need To Read

Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This selection of recent insights from our experienced on-the-ground team will help.

Topics

UsernamePublicRestriction

Register

OM010563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel